4 citations
,
October 2016 This source describes the potential of various herbal treatments, such as aloe vera and amla, as natural alternatives for managing hair loss and enhancing hair health, noting their benefits include fewer side effects, affordability, and multiple application methods.
4 citations
,
September 2011 in “Expert Review of Dermatology” This review discusses various treatment options for alopecia areata, noting a lack of consensus on grading and treatment algorithms, and reports no new clinical results.
3 citations
,
April 2019 in “Journal of Dermatological Treatment” This review discusses the use of phosphodiesterase inhibitors for alopecia, finding promising preliminary results with topical caffeine for androgenetic alopecia and telogen effluvium, but limited success in alopecia areata.
3 citations
,
January 2010 in “Actas Dermo-Sifiliográficas” This study found that a history of immunization and throat carriage of bacterial pathogens, including Streptococcus pyogenes, were associated with increased risk of developing alopecia areata.
3 citations
,
October 1993 in “The Journal of Dermatology” This article reviews the diagnosis and treatment of clinical hair loss without providing new clinical results.
2 citations
,
October 2024 in “Dermatology and Therapy” In this study, dermatologists expressed low satisfaction with traditional treatments for severe alopecia areata, noting that some patients stop treatment due to disease worsening, indicating a need for more effective options.
2 citations
,
March 2023 in “3C Empresa Investigación y pensamiento crítico” In this study, patients with alopecia areata showed significantly elevated serum levels of IFN-γ and severely deficient vitamin D3 levels compared to healthy controls.
2 citations
,
January 2019 in “Dermatology Review” This study found that pigmented vellus and upright regrowing hairs are the only predictive trichoscopic markers of hair regrowth in patients with alopecia totalis and universalis.
2 citations
,
January 2018 in “International journal of research in dermatology” This study found that intralesional corticosteroids remain the preferred treatment for alopecia areata with limited involvement, while platelet-rich plasma showed promise, particularly in children and extensive cases.
2 citations
,
February 2014 in “Hair therapy & transplantation” This article reviews the autoimmune mechanism and potential environmental triggers of alopecia areata, focusing on cytokines, but does not provide new research findings.
This chapter reviews the prevalence, pathogenesis, and management of hair and scalp disorders but reports no new clinical findings.
1 citations
,
November 2025 in “Clinical and Experimental Medicine” This review highlights the emerging role of long non-coding RNAs (lncRNAs) in dermatology, suggesting that lncRNAs significantly impact signaling pathways involved in normal skin functions and skin diseases, offering potential as biomarkers and therapeutic targets.
1 citations
,
July 2024 in “PharmacoEconomics - Open” This study indicates that the EQ-5D-5L may not effectively capture the burden of alopecia areata on patients' health-related quality of life, and suggests that alternative measures might better assess treatment benefits related to hair regrowth.
1 citations
,
May 2024 in “Dermatology and Therapy” This review article examines the current understanding of frontal fibrosing alopecia, noting its prevalence in different demographics and the roles of genetic and environmental factors in its pathogenesis, while highlighting that treatment approaches remain varied and lack standardization.
1 citations
,
October 2023 in “Dermatology and therapy” This review concluded that baricitinib and other oral JAK inhibitors have the most robust evidence supporting their use in treating severe alopecia areata in adults, compared to other less-evaluated treatments.
1 citations
,
October 2023 in “International journal of Ayurveda and pharma research” This source reviews various herbal remedies for treating hair loss, highlighting their potential benefits and reduced side effects compared to synthetic treatments, which often do not deliver lasting results and can cause adverse reactions.
1 citations
,
July 2023 in “Al-Azhar Medical Journal” This study observed a significant association between antigliadin antibodies (IgA and IgG) and alopecia areata severity, suggesting that serological tests could help diagnose subclinical celiac disease in these patients, with IgA and IgG showing 100% sensitivity and specificity at specific cutoff points.
1 citations
,
November 2017 in “Journal of Investigative Dermatology” This review discusses the potential use of platelet-rich plasma and microneedling for alopecia areata and reports encouraging findings, but no new clinical results; future research is needed to validate these treatments.
1 citations
,
May 2017 in “Journal of The American Academy of Dermatology” In this study, increasing cases of allergic contact dermatitis in Bulgaria were linked to the use of natural products like propolis and marigold.
1 citations
,
May 2017 in “Journal of The American Academy of Dermatology” This study found that the increasing use of natural products like propolis and calendula officinalis in Bulgaria is linked to a growing number of allergic contact dermatitis cases, predominantly in women.
1 citations
,
May 2017 in “InTech eBooks” This review addresses alopecia areata, emphasizing its autoimmune nature, unpredictable course, and lack of preventive or curative treatments, while noting standard and emerging therapies such as topical steroids and Janus kinase inhibitors.
1 citations
,
January 2015 in “Springer eBooks” The document says a skin condition called alopecia areata causes hair loss and stress, and is treated with strong skin creams, injections, or other therapies, but treatment success varies.
1 citations
,
October 2013 in “Expert Review of Dermatology” This paper reviews the differential diagnoses and diagnostic tests to distinguish alopecia areata from other types of hair loss, without providing new clinical findings.
April 2026 in “International Journal of Drug Delivery Technology” This review highlights the various causes and treatment options for alopecia, noting that while non-scarring types often see successful hair regrowth, scarring forms require early intervention to manage inflammatory destruction of hair follicles.
In this phase 2 trial, STS01 1% significantly improved hair regrowth in patients with mild to moderate patchy alopecia areata compared to placebo, with a manageable skin irritation side effect profile.
February 2026 in “Frontiers in Medicine” This case series described five patients with chronic alopecia areata who successfully maintained long-term disease control using a combination of topical immunotherapy and other treatments over 9–15 years, highlighting the approach's continued value alongside novel therapies.
January 2026 in “Forum Dermatologicum” This article reviews the regenerative benefits of platelet-rich plasma in various medical fields, particularly in dermatology and aesthetic medicine, without presenting new clinical data.
JAK inhibitors effectively regrow hair in alopecia areata but hair loss often returns after stopping treatment.
December 2025 in “Cureus” This study suggests that elevated levels of IL-17A and IL-23 in alopecia areata may play roles in disease severity and activity, providing insights into potential therapeutic targets.
November 2025 in “International Journal For Multidisciplinary Research” This study focused on treating 'Indralupta' or alopecia areata using Ayurvedic methods such as Prachanna Karma, finding it promising for improving perifollicular vascularization and addressing hair loss attributed to vitiated Rakta as defined by traditional texts.